Status: current, Defined. Date: 31-Oct 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4220801000168113 | alpha-1-proteinase inhibitor 1 g / 20 mL injection, 20 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4220811000168111 | alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | Is a | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 257699421 | |
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | has intended active ingredient | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | 257699420 | |
| alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | has Australian BoSS | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | 257699420 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| alpha-1-proteinase inhibitor 1 g/20 mL injection, 20 mL vial | has MPUU | True | alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | Inferred relationship | Some | 1 |
| Prolastin C Liquid 1 g/20 mL injection, 20 mL vial | Is a | True | alpha-1-proteinase inhibitor 1 g/20 mL injection, vial | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR